Business Value: inspira-technologies.com (IINN)

Brandmark of inspira-technologies.com (IINN)

Inspira Technologies Oxy (IINN) develops respiratory devices for which demand is driven by medical necessity regardless of economic fluctuations. The price action available for analysis on GURU.Markets has fixed the business valuation at 14.86. Diversified component procurement and precision assembly support stable profits. Meanwhile, expansion in the blood oxygenation market is accelerating due to the implementation of less invasive therapy methods.

Inspira Technologies (IINN) - Real Price to Acquire Entire Company from 11/23/2025 to 05/20/2026
Brand item of inspira-technologies.com

Assessing the operational strength of Inspira Technologies Oxy (IINN) assets requires an analysis of the total business acquisition costs. The scaling of robotic production lines for EKRP systems and the implementation of AI telemetry directly impact capital expenditure. This enterprise value chart, combining market capitalization with net debt, reflects the actual price of seizing control. An increase in this metric amid limited cash reserves may signal overvaluation, while a stable trajectory confirms the fundamental resilience of the technological transformation.

Who Inspira Technologies Oxy competes with

Company Buyout Price DexCom Inc (DXCM)|PEN - Total Company Value|NOVT (Novanta Photonics) - Business Value|Haemonetics Corporation (HAE) - Total Company Value|Business Value INSP|Real Price to Acquire Entire Company PRCT|CNMD (CONMED Corp) - Aggregate Business Value|Enterprise Value PLSE|INMD (InMode MD) - Value Adjusted for Debt and Cash|Enterprise Value PMI (Picard Medical Inc)|surmodics.com (SRDX) - Total Enterprise Value|SENS - Total Company Value|Value Adjusted for Debt and Cash NPCE (NeuroPace Inc)|TCMD: Enterprise Value|SANUWAVE Health Inc (SNWV) - Enterprise Value|Total Company Value Outset Medical, Inc.|Electromed Inc - Full Business Value|Enterprise Value LNSR|RCEL - Total Enterprise Value|Profound Medical - Real Price to Acquire Entire Company|Enterprise Value Baird Medical Investment Holdings BDMD|EDAP: Real Price to Acquire Entire Company|Apyx Medical - Aggregate Business Value|ICCM: Enterprise Value|LUNG - Company Buyout Price|TELA (TELA Bio Inc.) - Enterprise Value|Real Price to Acquire Entire Company CytoSorbents Corp. (CTSO)|Real Price to Acquire Entire Company SRTS (Sensus Healthcare, Inc.)|ZYXI (zynex.com) - Value Adjusted for Debt and Cash|Total Company Value electroCore ECOR|RBOT - Real Price to Acquire Entire Company|SeaStar Medical Holding Corp - Enterprise Value|Total Enterprise Value IRIDEX Corporation|INBS: Enterprise Value|Business Value XAIR|PFSA (Profusa) - Enterprise Value|STRATA Skin (SSKN) - Company Buyout Price|Enterprise Value GCTK|Real Price to Acquire Entire Company nanovibronix.com NAOV|Enterprise Value VERO (Venus Concept Inc.)|Enterprise Value nuwellis.com NUWE|AEMD - Total Company Value|ASXC: Total Company Value|AVGR (Avinger, Inc) - Real Price to Acquire Entire Company|BioSig - Value Adjusted for Debt and Cash|CUTR (Cutera, Inc.) - Enterprise Value|Total Enterprise Value knowlabs.co KNW|Total Company Value Inari Medical (NARI)|Nevro Corp (NVRO) - Full Takeover Company Value|ReShape Lifesciences Inc. - Real Price to Acquire Entire Company|Enterprise Value Silk Road Medical Inc SILK